Drugs: Thousand Oaks drug maker Amgen Inc. released a mixed forecast for 2007, predicting its net income for the year would come in below expectations.

Drugs: Thousand Oaks drug maker Amgen Inc. released a mixed forecast for 2007, predicting its net income for the year would come in below expectations. First-quarter net income tallied $1.11 billion, or $0.94 per diluted share, compared to $1 billion--$0.82 a share--in the year-ago period. Revenue grew to $3.69 billion, an increase of 15 percent, but below analyst expectations of $3.73 billion. Amgen now predicts its end-year earnings will be at the low end of its $4.30 to $4.50 a diluted share guidance.